Back to Agenda
The Future of Patient Engagement: Measuring What Matters
Session Chair(s)
Debra Lappin, JD
Head, Health Biosciences Practice , FaegreBD Consulting, United States
As awareness and theory around patient engagement in the medical product life cycle have matured, stakeholders are now focusing on best practices and implementation of patient centric strategies. In this session, patient, industry, and regulatory stakeholders will share their perspectives on today’s meaning of effective engagement and what the future state of patient engagement will look like. Panelists will discuss what they believe should be the outcomes of their investments of effort and how we can engage patients to identify the outcomes that matter most. The idea of “return on engagement” will be explored: how do we measure what matters? How do we turn insights into regulatory utilities? And how do we capture the return – to drug and device development – on this investment in patient engagement?
Join Patient Engagement Community for a follow up Round Table discussion at 12:30pm in the Community Corner.
Learning Objective : Describe the meaning of effective patient engagement and where it should take place during the medical product life cycle; Discuss approaches to involving patients in the determination of meaningful outcomes throughout the life cycle of medical therapies; Identify potential measures that could demonstrate the return on meaningful engagement for patient, regulatory, and industry stakeholders. Explore patient engagement in today’s policy environment and in the context of global harmonization.
Speaker(s)
Anne C. Beal, MD, MPH
Senior VP, Chief Patient Officer and Global Head of Patient Centricity, Sanofi, France
Panelist
Juan Garcia-Burgos, MD, PHD
Head of Public and Stakeholders Engagement Department, European Medicines Agency, Netherlands
Panelist
K. Kimberly McCleary
Founder and Chief Executive Officer, The Kith Collective, LLC, United States
Panelist
Paul Kluetz, MD
Deputy Director, Oncology Center of Excellence, OC, FDA, United States
Panelist
Ronald Joseph Bartek, MA
Co-Founder/Founding President, Friedreich's Ataxia Research Alliance (FARA), United States
Panelist
Have an account?